Shuai Qu obtained his B.S. diploma in Bioengineering from Harbin Institute of Expertise in 2018. He’s presently pursuing the Ph.D. diploma at Peking College, below the path of Prof. Zhifei Dai. His analysis focuses on the event of superior gene supply programs for atherosclerotic and most cancers remedy.
Renfa Liu obtained his Ph.D. diploma from the Gorgia Tech, Emory & Peking College biomedical engineering Ph.D. program in 2020. He’s presently a postoctor on the Division of Biomedical Engineering, Peking College. His analysis pursuits embody the event of micro-/nano- supplies for the theranostic purposes in most cancers and cardiovascular illnesses using mild and/or ultrasound.
Zhifei Dai is a professor on the Division of Biomedical Engineering, Peking College. He obtained his Ph.D. diploma from Technical Institute of Physics and Chemistry, CAS, in 1998. Prof. Dai’s analysis is targeted on refined biomaterials and nanotechnology for the event of superior drug supply programs, molecular imaging and sensing of diseased cells and organs. He has revealed over 200 scientific journal papers on peer-reviewed journals, and delivered over 100 plenary/keynote/invited talks on numerous conferences, received two first prizes of Provincial and Ministerial Pure Science and the P & G Instructor Award. Prof. Dai sits on the affiliate editor of Bioconjugate Chemistry and the editorial board of a number of peer-reviewed journals, serves as Chairman of Distinction Enhanced Imaging Expertise Department of China Pharmaceutical Biotechnology Affiliation and Chairman Designate of Nano Oncology Department of China Anti Most cancers Affiliation.
© 2022 Elsevier Ltd. All rights reserved.